Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases-Reference-Cited by-同舟云学术

Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases

Published:2004-07 Issue:7 Volume:12 Page:1325-1334
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Somoza John R,Skene Robert J,Katz Bradley A,Mol Clifford,Ho Joseph D,Jennings Andy J,Luong Christine,Arvai Andrew,Buggy Joseph J,Chi Ellen,Tang Jie,Sang Bi-Ching,Verner Erik,Wynands Robert,Leahy Ellen M,Dougan Douglas R,Snell Gyorgy,Navre Marc,Knuth Mark W,Swanson Ronald V,McRee Duncan E,Tari Leslie W

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference40 articles.

1. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA);Almenara;Leukemia,2002

2. Histone deacetylases;Ayer;Trends Cell Biol.,1999

3. Crystallography & NMR system;Brünger;Acta Crystallogr. D.,1998

4. Cloning and characterization of a novel human histone deacetylase, HDAC8;Buggy;Biochem. J.,2000

5. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities;David;J. Biol. Chem.,2002

Cited by 633 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50;Molecular Cell;2024-02

2. Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma;Archiv der Pharmazie;2024-01-31

3. HDAC inhibitor derivatives induce differentiation of leukemic cells through two distinct and separable mechanisms;2024-01-07

4. Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation;Results in Chemistry;2024-01

5. A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency;PLOS Pathogens;2023-12-19